KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Account Payables: 2009-2024

Historic Change in Account Payables for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to -$33.0 million.

  • Emergent BioSolutions' Change in Account Payables rose 82.61% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.0 million, marking a year-over-year decrease of 0.33%. This contributed to the annual value of -$33.0 million for FY2024, which is 411.32% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Change in Account Payables of -$33.0 million as of FY2024, which was down 411.32% from $10.6 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Change in Account Payables ranged from a high of $28.3 million in FY2020 and a low of -$33.0 million during FY2024.
  • In the last 3 years, Emergent BioSolutions' Change in Account Payables had a median value of -$14.0 million in 2022 and averaged -$12.1 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Change in Account Payables tumbled by 775.00% in 2022, and later skyrocketed by 175.71% in 2023.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Change in Account Payables stood at $28.3 million in 2020, then slumped by 105.65% to -$1.6 million in 2021, then tumbled by 775.00% to -$14.0 million in 2022, then soared by 175.71% to $10.6 million in 2023, then tumbled by 411.32% to -$33.0 million in 2024.